|25.89||+0.97 / +3.89%|
As of 3:59pm ET
|25.15||-0.74 / -2.84%|
The 5 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 32.00, with a high estimate of 45.00 and a low estimate of 30.00. The median estimate represents a +23.60% increase from the last price of 25.89.
The current consensus among 5 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.